XML 46 R35.htm IDEA: XBRL DOCUMENT v3.4.0.3
SHAREHOLDERS' EQUITY (Tables)
 3 Months Ended
Mar. 31, 2016
Stockholders' Equity Note [Abstract]  
Schedule of shareholders' equity
 
Valeant Pharmaceuticals International, Inc. Shareholders
 
 
 
 
 
Common Shares
 
Additional
Paid-In
Capital
 
Accumulated
Deficit
 
Accumulated
Other
Comprehensive
Loss
 
Valeant
Pharmaceuticals
International, Inc.
Shareholders’
Equity
 
Noncontrolling
Interest
 
Total
Equity
 
Shares
(in millions)
 
Amount
 
 
 
 
 
 
Balance, January 1, 2015 (restated)
334.4

 
$
8,349.2

 
$
243.9

 
$
(2,397.8
)
 
$
(915.9
)
 
$
5,279.4

 
$
122.3

 
$
5,401.7

Issuance of common stock (see below)
7.3

 
1,431.9

 
—

 
—

 
—

 
1,431.9

 
—

 
1,431.9

Common shares issued under share-based compensation plans
0.6

 
29.2

 
(14.7
)
 
—

 
—

 
14.5

 
—

 
14.5

Share-based compensation
—

 
—

 
35.0

 
—

 
—

 
35.0

 
—

 
35.0

Employee withholding taxes related to share-based awards
—

 
—

 
(21.2
)
 
—

 
—

 
(21.2
)
 
—

 
(21.2
)
Excess tax benefits from share-based compensation
—

 
—

 
17.9

 
—

 
—

 
17.9

 
—

 
17.9

 
342.3

 
9,810.3

 
260.9

 
(2,397.8
)
 
(915.9
)
 
6,757.5

 
122.3

 
6,879.8

Comprehensive loss:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (restated)
—

 
—

 
—

 
97.7

 
—

 
97.7

 
0.8

 
98.5

Other comprehensive loss
—

 
—

 
—

 
—

 
(411.7
)
 
(411.7
)
 
(0.2
)
 
(411.9
)
Total comprehensive loss (restated)
 
 
 
 
 
 
 
 
 
 
(314.0
)
 
0.6

 
(313.4
)
Balance, March 31, 2015 (restated)
342.3

 
$
9,810.3

 
$
260.9

 
$
(2,300.1
)
 
$
(1,327.6
)
 
$
6,443.5

 
$
122.9

 
$
6,566.4

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, January 1, 2016
342.9

 
$
9,897.4

 
$
304.9

 
$
(2,749.7
)
 
$
(1,541.6
)
 
$
5,911.0

 
$
118.8

 
$
6,029.8

Common shares issued under share-based compensation plans
0.1

 
8.5

 
(7.7
)
 
—

 
—

 
0.8

 
—

 
0.8

Share-based compensation
—

 
—

 
63.5

 
—

 
—

 
63.5

 
—

 
63.5

Employee withholding taxes related to share-based awards
—

 
—

 
(7.7
)
 
—

 
—

 
(7.7
)
 
—

 
(7.7
)
Excess tax expense from share-based compensation
—

 
—

 
(1.4
)
 
—

 
—

 
(1.4
)
 
—

 
(1.4
)
 
343.0

 
9,905.9

 
351.6

 
(2,749.7
)
 
(1,541.6
)
 
5,966.2

 
118.8

 
6,085.0

Comprehensive (loss) income:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net (loss) income
—

 
—

 
—

 
(373.7
)
 
—

 
(373.7
)
 
0.8

 
(372.9
)
Other comprehensive income
—

 
—

 
—

 
—

 
63.0

 
63.0

 
0.5

 
63.5

Total comprehensive (loss) income
 
 
 
 
 
 
 
 
 
 
(310.7
)
 
1.3

 
(309.4
)
Balance, March 31, 2016
343.0

 
$
9,905.9

 
$
351.6

 
$
(3,123.4
)
 
$
(1,478.6
)
 
$
5,655.5

 
$
120.1

 
$
5,775.6